Skip to main content
ABT logo

ABT · Abbott Laboratories · Analyst Estimates

Track ABT — free
$98.97 -1.98 (-1.96%)
Market Cap
$174.90B
Shares
1.74B
Volume · Sep 30 3.35M Avg daily vol (3M) 9.76M

Analyst Estimates

Compare analyst forecasts for Abbott Laboratories across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-18 20:28 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
5.48
5.51967
5.57
—
5.51806
5.48226
5.51886
5.48325
— — — —
EPS
analysts
Publication date not stated
— — —
26
— — — —
1
0
5
1
Revenue
USD
Publication date not stated
47608270000
50204139350
50776777380
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
27
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
5.88
6.06545
6.2
—
6.06367
6.05258
6.06487
6.05932
— — — —
EPS
analysts
Publication date not stated
— — —
26
— — — —
2
0
3
1
Revenue
USD
Publication date not stated
51416930000
54527640150
55360613990
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
27
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
1.41
1.41953
1.44
—
1.41953
1.42199
1.41953
1.41993
— — — —
EPS
analysts
Publication date not stated
— — —
22
— — — —
10
1
7
1
Revenue
USD
Publication date not stated
12898000000
12991669020
13157000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
24
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
1.59
1.63784
1.66739
—
1.63784
1.62001
1.63784
1.61894
— — — —
EPS
analysts
Publication date not stated
— — —
22
— — — —
0
0
15
1
Revenue
USD
Publication date not stated
13346800000
13541643160
13742352430
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
24
— — — — — — — —
Key facts CIK 1800 CUSIP 002824100 13F (30d) 87 filings 37 filers Visit website